Stockwinners Market Radar for June 16, 2022 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:09 EDT Cathie Wood's ARK Investment bought 78K shares of 3D Systems today

20:07 EDT Cathie Wood's ARK Investment bought 5.2K shares of Tesla today

19:46 EDT PDF Solutions CFO sells $796K in common stock - In a regulatory filing, PDF Solutions disclosed that its CFO Adnan Raza sold 39.4K shares of common stock on June 14th in a total transaction size of $796.5K.

19:21 EDT ZipRecruiter announces $150M increase to share buyback program - ZipRecruiter "announced its board of directors has authorized a $150M increase to the company's share repurchase program. This is in addition to the previous authorization of $100M. As of June 15, 2022, approximately $6.6 million in shares of the company's Class A common stock was available for future repurchases under the company's share repurchase program. As a result of the increase, an aggregate of approximately $156.6M in shares of the company's Class A common stock is available for future repurchases under the company's share repurchase program."

18:16 EDT HomeStreet director buys $870K in common stock - In a regulatory filing, HomeStreet discloses that its director Mark Patterson bought 25K shares of common stock on June 14th in a total transaction size of $870.2K.

18:05 EDT Expro approves $50M share repurchase program - Expro Group Holdings has announced that the Company's Board of Directors has authorized a stock repurchase program, under which the Company may repurchase up to an aggregate of $50M of its outstanding common stock until November 24, 2023 in compliance with Rule 10b-18 under the Securities Exchange Act of 1934.

17:59 EDT Aerojet's Lichtenstein supports pre-releasing preliminary results pre meeting - Aerojet Rocketdyne Holdings (AJRD), Executive Chairman Warren Lichtenstein, who collectively with his affiliates and the participants in his solicitation owns approximately 5.6% of the Company's outstanding shares, issued the below statement ahead of a special meeting of shareholders scheduled to be held on June 30. "As a reminder, Mr. Lichtenstein is seeking support on the Green Proxy Card to elect his recently refreshed slate of highly qualified candidates to the Company's Board of Directors. "Given that Aerojet Rocketdyne's future hangs in the balance at the June30th Special Meeting, the Company's shareholders should be promptly provided as much information as possible to inform their voting decisions.This is why I support pre-releasing preliminary results for the first five months of this fiscal year, including revenue, earnings and cash flow, and doing so in a manner that compares these metrics to management's plans.Three other members of the Company's eight-member Board support this action as well. Shareholders deserve to know whether the financial and operational deterioration that has set in since December 2020, when the Lockheed Martin (LMT) deal was announced and Mark Tucker stepped down as COO, has worsened over the past five and a half months as CEO Eileen Drake leveraged the boardroom gridlock she had facilitated to operate the Company with even greater impunity, said Lichtenstein and new CEO candidate Mark Tucker have issued a detailed presentation that diagnoses Aerojet Rocketdyne's vulnerabilities and outlines a fix-and-repair plan that targets at least $65 per share within three years," noted Lichtenstein.

17:40 EDT Vinci Partners approves share buyback and share repurchase plans - Vinci Partners Investments announced that its board of directors approved a share buyback plan and a share repurchase plan to buy back up to R$60.0M of the Company's outstanding Class A common shares across both plans. These plans are approved to replace the share repurchase plans approved by our board of directors on May 6, 2021, September 15, 2021, and December 1st, which expired on May 31st. The plans will commence immediately and will not have specified expiration date. Vinci Partners expects to finance the purchases with existing cash balances derived from its Distributable Earnings, which is not expected to have a material impact on capital levels.

17:31 EDT Adobe says factoring in foreign exchange headwind on Q3, Q4 - Sees Q3 effective tax rate 18.5%. Sees $75M revenue impact on digital media business in Q3. Says factoring in $175M in foreign exchange headwind on Q3 and Q4 revenue. Sees FY22 effective tax rate 18.5%. Says pleased with execution in Q2. Says reduced expected impact of increased tax rate foreign exchange headwinds. Says on track for another year of record revenue and operating cash flow. Comments and guidance taken from Q2 earnings conference call.

17:18 EDT Lockheed Martin awarded $130.53M Air Force contract modification - Lockheed Martin has been awarded a $130.53M contract modification to a previously awarded contract for the Advanced Radar Threat System - Variant 2, or ARTS-V2. The contract modification is to provide for the exercise of Options Three and Four for an additional quantity of eight ARTS-V2 systems being produced under the basic contract. Work is expected to be completed by June 16, 2024. FY21 and FY22 other procurement funds are being obligated at the time of award. The total cumulative face value of the contract is $589.81M. Air Force Life Cycle Management Center is the contracting activity.

17:15 EDT BAE Systems awarded $698.97M Army contract - BAE Systems was awarded a $698.97M cost-plus-fixed-fee contract for Defense Supercomputing Resource Center operations, maintenance, and management services, including program-wide services for high-performance computer users. Bids were solicited via the internet with four received. Work locations and funding will be determined with each order, with an estimated completion date of June 15, 2027. U.S. Army Corps of Engineers is the contracting activity.

17:04 EDT Adobe falls about 4% to $351 after below-consensus Q3, FY22 guidance

16:48 EDT Targa Resources expects Lucid acquisition to be accretive to cash flow per share - "The acquisition is expected to be immediately accretive to distributable cash flow per share. This acquisition further supports our already strong cash flow profile and ability to return an increasing amount of capital to our shareholders through common dividend increases and common share repurchases," added CEO Matt Meloy.

16:44 EDT Targa Resources to acquire Lucid Energy for $3.55B - Targa Resources and Lucid Energy Group, a privately held natural gas processor in the Permian Basin, announced a definitive agreement under which a wholly-owned subsidiary of Targa will acquire Lucid Energy from Riverstone Holdings and Goldman Sachs Asset Management, for $3.55B in cash. Lucid provides natural gas gathering, treating, and processing services in the Delaware Basin, including approximately 1,050 miles of natural gas pipelines and approximately 1.4B cubic feet per day of cryogenic natural gas processing capacity in service or under construction located primarily in Eddy and Lea counties of New Mexico. Lucid's Delaware Basin footprint overlays some of the most economic crude oil and natural gas producing acreage in North America. Current rig activity supports over 20 years of drilling inventory on Lucid's greater than 600,000 dedicated acres, which are further supplemented by significant volumes subject to minimum volume commitments. Lucid's assets are anchored by long-term, fixed-fee contracts and acreage dedications from a diverse set of high-quality customers. Approximately 70% of current system volumes are sourced from investment grade producers. Completion of this transaction is subject to customary closing conditions, including regulatory approvals. The transaction is expected to close in the third quarter of 2022. Targa has available liquidity, including cash on hand, its existing $2.75B revolving credit facility, and committed debt financing to fund the acquisition.

16:36 EDT Rhythm Pharmaceuticals falls 15% to $3.30 after Alstrom syndrome CRL

16:35 EDT Clearlake-backed Wheel Pros to acquire Transamerican Auto Parts from Polaris - Wheel Pros, a designer, manufacturer and distributor of proprietary branded aftermarket vehicle enhancements for light trucks, SUVs, passenger cars and ATVs/UTVs backed by Clearlake Capital Group, and in partnership with management, announced it has entered into a definitive agreement to acquire Transamerican Auto Parts from Polaris .TAP is a vertically integrated manufacturer, distributor, retailer and installer of off-road Jeep and light truck parts and accessories. In 2021, TAP generated nearly $760M in revenue.

16:32 EDT W.P. Carey increases quarterly cash dividend to $1.06 per share - W. P. Carey reported that its board of directors increased its quarterly cash dividend to $1.06 per share, equivalent to an annualized dividend rate of $4.24 per share. The dividend is payable on July 15 to stockholders of record as of June 30.

16:31 EDT PlayAGS issues statement on Supreme Court's Texas gambling ruling - AGS CEO David Lopez issued the following statement after the announcement of the United States Supreme Court decision siding with certain Tribes in Texas to allow bingo gaming on their Tribal lands, without regulatory oversight from the State of Texas. The court's ruling on Wednesday determined that these Texas Tribes have the autonomy to regulate electronic bingo games on their lands, in compliance with the Indian Gaming Regulatory Act like most other Tribes in America, regardless of the state's rules on bingo, which is permitted in the State of Texas. While the federal government agreed with the Tribes' position, the State of Texas did not. "After an extremely long process in the judicial system, I would like to congratulate our Native American business partners and friends on their well-deserved win. This ruling makes it possible for these sovereign Tribes to gain economic freedom and confirms their rights as federally recognized Tribes. AGS stands by our Tribal operator partners as they look to exercise their rights and wish them success in current and future ventures as sovereign Tribes in the State of Texas. We are proud to support all our Native American partners throughout the country, and, in particular, these Tribes that have fought so hard and so long in pursuit of their economic freedom."

16:30 EDT Rhythm enters revenue financing agreement with HealthCare Royalty - Rhythm Pharmaceuticals announced that it has entered into a revenue interest financing agreement with HealthCare Royalty Partners for a total investment amount of up to $100M. Rhythm intends to use the proceeds from the agreement and its cash on hand to support global commercialization efforts for Imcivree and ongoing clinical development. Under the terms of the agreement, Rhythm will receive an initial investment amount of $37.5M from HealthCare Royalty, as a result of the approval of Imcivree by the FDA for the treatment of obesity and control of hunger in adult and pediatric patients six years old and older with Bardet-Biedl syndrome. Rhythm will receive an additional investment amount of $37.5M following European Commission marketing authorization for Imcivree for BBS, which is anticipated in the second half of 2022. The final investment amount of $25M will be payable upon Rhythm's achievement of certain agreed sales milestones in 2023. In exchange for the total investment amount received by Rhythm, HealthCare Royalty will receive a tiered royalty based on global net product sales generated by Imcivree. This royalty will begin in the low double digits and decrease to the low single digits upon the achievement of certain annual revenue thresholds. The total royalty payable by Rhythm to HealthCare Royalty is capped between 185% and 250% of the amount paid to Rhythm, dependent on the aggregate royalty paid between 2028 and 2032. Rhythm anticipates that it will be able to fund its operating expenses and capital expenditure requirements into the second half of 2024, regardless of whether the sales milestone relating to the third tranche is achieved.

16:17 EDT Universal Logistics announces preliminary results of its tender offer - Universal Logistics Holdings announced the preliminary results of its modified "Dutch auction" tender offer to repurchase up to 100,000 shares of its outstanding common stock, which expired at 5:00 p.m., Eastern Time, on Wednesday, June 15. Based on the preliminary count by Computershare Trust Company, the depositary for the tender offer, approximately 164,189 shares were properly tendered and not properly withdrawn at or below the expected final purchase price of $28.00 per share, including shares that were tendered through notices of guaranteed delivery. In accordance with the terms and conditions of the tender offer, the Company expects to acquire 164,189 shares at a final purchase price of $28.00 per share, for an aggregate purchase price of approximately $4.6M. These shares represent approximately 0.62% of the Company's issued and outstanding shares as of May 12. The total amount of shares expected to be purchased in the tender offer includes the Company's right to increase the tender offer by up to two percent of the Company's outstanding shares and also includes a total of 5,000 shares tendered by Mr. H.E. "Scott" Wolfe, a director of the Company. The determination of the final number of shares to be purchased and the final price per share is subject to confirmation by Computershare of the proper delivery of the shares validly tendered and not withdrawn.

16:16 EDT Citi Trends names Heather Plutino as new CFO - Citi Trends "announced that Heather Plutino has been appointed CFO effective June 27, 2022. Ms. Plutino joins Citi Trends after serving as Senior Vice President of Enterprise Financial Planning & Analysis and Commercial Finance at Bed Bath & Beyond."

16:14 EDT Lava updates LAVA-051 program for CLL and MM at ASCO - Lava Therapeutics hosted a clinical update call focused on encouraging initial Phase 1/2a clinical data for LAVA-051 in patients with chronic lymphocytic leukemia and multiple myeloma patients following poster presentations at the 2022 American Society of Clinical Oncology Annual Meeting held June 3-7, 2022, and the European Hematology Association 2022 Congress, held June 9-12, 2022. "While treatment options for hematologic malignancies such as CLL and MM have advanced in recent years, a large number of patients who do not respond adequately to current therapies need new options," said Arnon Kater, M.D., Ph.D., chairman of the Dutch/Belgium HOVON CLL working group and professor of translational hematology at the Amsterdam University Medical Center, and LAVA-051 clinical trial investigator. "Although preliminary, these data support our view of LAVA-051 as a promising therapeutic candidate that has the potential to overcome challenges of existing T-cell approaches which frequently show cytokine release syndrome very close to their efficacious dose. The early clinical data from the first four cohorts presented at this year's ASCO and EHA meetings demonstrate early signals of potential anti-tumor activity in CLL and MM patients, as well as an attractive safety profile. Importantly, the pharmacodynamic determinations gathered from the patients in this early clinical study reflect the mechanism of action of LAVA-051."

16:13 EDT Eagle Bancorp increases cash dividend to 45c per share - Eagle Bancorp announced a cash dividend for the second quarter of 2022, in the amount of 45c per share, a 5c per share increase from the prior quarter's dividend. The cash dividend will be payable on July 29 to shareholders of record on July 11.

16:09 EDT Atreca appoints Stephen Gould as chief scientific officer - Atreca announced the appointment of Stephen Gould as chief scientific officer. Gould is joining Atreca following 15 years at Genentech, where he held positions of increasing responsibility, most recently serving as executive director, translational oncology

16:08 EDT Rhythm Pharmaceuticals announces FDA approval for Imcivree SNDA - Rhythm Pharmaceuticals announced that the FDA has approved the company's supplemental new drug application, or sNDA, for Imcivree, a melanocortin-4 receptor, or MC4R, agonist, for patients with Bardet-Biedl syndrome, or BBS. With this approval, Imcivree is indicated for chronic weight management in adult and pediatric patients six years old and older with monogenic or syndromic obesity due to proopiomelanocortin, or POMC, proprotein convertase subtilisin/kexin type 1, or PCSK1, or leptin receptor deficiency, or BBS.

16:06 EDT Remitly Global names Rina Hahn as Chief Marketing Officer - Remitly "announced the appointment of Rina Hahn as Chief Marketing Officer. Hahn came to Remitly from Blue Nile where she served in a variety of roles including as the Director of Acquisition, overseeing global marketing for the company. She joined Remitly as the Director of Digital Marketing before moving to drive customer acquisition as the Vice President of Growth."

16:04 EDT Roku jumps over 3% to $81.25 after announcing shopping deal with Walmart

16:03 EDT Walmart to become exclusive partner for Roku for direct shopping on TV - Walmart (WMT) and Roku (ROKU) "announced a first-of-its-kind partnership to make TV streaming the next e-commerce shopping destination. Walmart will be the exclusive retailer to enable streamers to purchase featured products fulfilled by Walmart directly on Roku, America's #1 TV streaming platform. This unique partnership evolves shopping beyond the QR code and will change the way customers interact and shop TV and video content. The new experience offers product discovery with a seamless checkout experience, enabling purchase directly at the time of inspiration. This first pilot program fuses entertainment with the transactional world of commerce, unlocking an innovative and inspiring in-platform buying experience for customers that will continue to evolve. Viewers simply press "OK" with the remote on a shoppable ad and proceed to checkout with their payment details easily pre-populated from Roku Pay, Roku's payments platform. From there, tapping "OK" on the Walmart checkout page places the order. A Walmart purchase confirmation is then emailed with shipping, return, and support information."

15:52 EDT Ebix refutes short report's 'grossly misleading and erroneous allegations' - Ebix issued a response to an article published on June 16 by a short-selling position holder in Ebix common stock. "As the company's Indian subsidiary is currently under review for an initial public offering in India, Ebix is limited in its ability to respond to the article's specific contents. Ebix refutes the report's grossly misleading and erroneous allegations and reiterates that its financial reporting, including but not limited to all transactions from and within its EbixCash payment solutions offerings in India, and revenue recognition policies thereof, are accurate and appropriate and in compliance with GAAP and SEC reporting requirements. Since March 2021, the company has engaged the services of two independent auditors to audit the company's India businesses jointly, in addition to the engagement of counsel, Skadden, Arps, Slate, Meagher & Flom LLP, along with accounting experts from the consulting firm, AlixPartners LLP, to assist the company with respect to any issues related to the Gift card business. Having reviewed the work performed by AlixPartners and considering all their observations, the Board of Directors was satisfied that no steps were necessary with respect to the gift card business. Since then, the Company's consolidated independent auditors have completed the audit of the related consolidated statements of income, comprehensive income, stockholders' equity, and cash flows of the company for two calendar year periods ending December 2020 and December 2021 while expressing an unqualified opinion. In addition, two independent joint statutory auditors for the consolidated India business have audited the India business for the period ended March 2021 and the interim period from April 1, 2021 to September 30, 2021 and expressed an unqualified opinion on both - the consolidated India business and the Indian gift card subsidiary. The audited financial statements of the Indian businesses for the three years ended March 31, 2021 and the six months ended September 30, 2021 are included within the DRHP filing that was submitted for regulatory review in March 2022. RSM's previously issued reports on the company's consolidated financial statements and the company's internal controls over financial reporting for the fiscal year ended December 31, 2019 did not contain an adverse opinion or a disclaimer of opinion; nor were they qualified or modified as to uncertainty, audit scope, or accounting principles. Ebix's gift card business, which received the bulk of the report's attention, generated operating income of 1% or lower in the 12-month period ending December 2020 and December 2021, which were not material to Ebix's operating profit or net income in each of the two periods," the company stated in a press release.

15:49 EDT FDA approves Rhythm treatment for weight management in patients with BBS - The FDA approved Rhythm Pharmaceuticals' imcivree as a treatment for weight management in patients with Bardet-Biedl Syndrome, or BBS. Reference Link

15:06 EDT New Jersey reports May gaming revenue up 15.1% to $430.6M - Based upon filings with the New Jersey Division of Gaming Enforcement, total gaming revenue reported by casinos, racetracks, and their partners was $430.6M for May, reflecting a 15.1% increase from $374.2M reported in May 2021. For year-to-date, total gaming revenue reported by casinos, racetracks, and their partners was $2.03B reflecting a 18.1% increase from $1.72B reported in the prior period. Based upon filings with the Division of Gaming Enforcement, Total Casino Win for the nine casino hotel properties was $233M for May, reflecting growth of 9.3% compared to $213.1M for May 2021. Year-to-date total casino win for the nine casino hotel properties was $1.08B, reflecting growth of 20.7% compared to $895.9M for the prior period. For the month of May, internet gaming win reported by casinos and their partners was $136M, reflecting growth of 25.7% compared to $108.2M for the prior period. For the year-to-date period, internet gaming win reported by casinos and their partners was $681.4M, reflecting growth of 29.3% compared to $527.2M for the prior year-to-date period. Sports wagering gross revenue reported by casinos, racetracks, and their partners was $61.6M for May, reflecting a 16.4% increase when compared to $52.9M in the prior period. Sports wagering gross revenue reported by casinos, racetracks and their partners was $269.4M for the year-to-date, reflecting a 9.3% decline when compared to $297.1M for the prior period. Publicly traded companies in the space include Boyd Gaming (BYD), Caesars (CZR), Churchill Downs (CHDN), DraftKings (DKNG), Flutter Entertainment (PDYPY), Gan Limited (GAN), Las Vegas Sands (LVS), MGM Resorts (MGM), Penn National (PENN), William Hill (WIMHY) and Wynn Resorts (WYNN).

14:22 EDT Director of Franklin Street Hansen buys 100K shares of company stock - Director of Franklin Street Properties Brian Hansen purchased 100,000 shares of company stock at $3.95 per share between June 14 and June 16, for a total transaction value of $395,330.

14:05 EDT Coeptis' Mehalick sees untapped opportunity in Entolimod

14:05 EDT Coeptis CEO says SPAC merger allows up-listing with strong financing in place

12:45 EDT Zhong Yang Financial Group Ltd trading resumes

12:40 EDT Zhong Yang Financial Group Ltd trading halted, volatility trading pause

12:00 EDT Altice USA falls -14.1% - Altice USA is down -14.1%, or -$1.29 to $7.91.

12:00 EDT PROG Holdings falls -23.2% - PROG Holdings is down -23.2%, or -$5.56 to $18.42.

12:00 EDT Web Street, Inc. rises 14.1% - Web Street, Inc. is up 14.1%, or $7.39 to $59.92.

11:21 EDT T-Mobile to offer free in-flight connectivity on select flights starting June 21 - T-Mobile (TMUS) announced earlier what it calls its "latest Un-carrier move," Coverage Beyond, which the company said will expand coverage and keep customers connected on flights and in 210+ countries and destinations. Starting June 21, when touching down in a foreign country, T-Mobile customers will get 5GB of free high-speed data each month, up to 5G speeds where available, in 210+ countries and destinations on T-Mobile's Magenta MAX plan and on the Business Unlimited Ultimate plan. In addition, customers will get the same experience of 5GB of high-speed data in 11 European countries - Austria, Croatia, Czech Republic, Germany, Greece, Hungary, Macedonia, Montenegro, Poland, Romania and Slovakia - on Magenta, most business plans and equivalent Sprint plans thanks to T-Mobile's partnership with Deutsche Telecom (DTEGY), the company stated. T-Mobile also announced that it is working with in-flight Wi-Fi providers to give customers free connectivity with streaming all flight long on the biggest U.S. airlines. Delta (DAL), American (AAL) and Alaska Airlines (ALK) will launch first on select flights starting June 21. "United Airlines (UAL) will follow. And T-Mobile will continue to work hard to keep customers covered on even more airlines over time," T-Mobile stated.

10:37 EDT Perion Network down 8% after short report published by The Bear Cave - Perion Network shares are down $1.39, or 8%, to $17.11 after Edwin Dorsey wrote on his Bear Cave substack about "problems" at the company.

10:23 EDT Knightscope announces contract renewal from real estate developer - Knightscope announced that an alternative asset manager has renewed its Autonomous Security Robot contract for a 5th year for two locations in central Texas. This client develops and operates over 800 properties ranging from office to retail, logistics to multifamily, and hospitality to development.

10:16 EDT SUMR Brands stockholders approve acquisition by Kids2 - Summer Infant, doing business as SUMR Brands, announced that its stockholders have voted at a special meeting to adopt the previously announced definitive merger agreement pursuant to which the company will be acquired by Kids2, Inc. The closing of the transaction is expected to occur on or about June 22, subject to the satisfaction or permitted waiver of all remaining closing conditions. "We want to thank our stockholders for their support of our transaction with Kids2. Their vote of confidence was pivotal to closing this transaction, which will benefit our channel customers and, ultimately, the end consumers they serve," said Stuart Noyes, the company's CEO.

10:11 EDT Joann names Dryer interim CFO after unexpected death of CFO Susz - In a regulatory filing, Joann reported that Matt Susz, the company's Executive Vice President, Chief Financial Officer & Strategy, passed away unexpectedly on June 15. Following Mr. Susz's unexpected death, the company's board of directors has appointed, effective as of June 15, Tom Dryer, the company's Vice President and Controller, to serve as the company's interim Chief Financial Officer. Upon commencement of his appointment, Dryer assumed the duties of the company's principal financial officer and principal accounting officer. Dryer was appointed Vice President, Controller in December 2011 after serving as the company's Director, Financial Planning since May 2011, the filing noted.

10:03 EDT Connexa Sports expands technology partnership with Pioneer Baseball League - Connexa Sports Technologies announced that its wholly owned subsidiary, PlaySight Interactive has expanded its technology partnership with the Pioneer Baseball League presented by TicketSmarter. The PBL was the first minor baseball league to partner with PlaySight for its video infrastructure needs and made headlines last season with the introduction of its "Knockout Round" that resolves tied games with a home run duel. Connexa Sports has also partnered with the league's newest organization for this season, the Northern Colorado Owlz, who are playing their home games out of the Future Legends Complex in Windsor, CO.

10:00 EDT Sally Beauty falls -12.7% - Sally Beauty is down -12.7%, or -$1.71 to $11.75.

10:00 EDT Daily S&P Biotech Bear 3x Shares rises 9.2% - Daily S&P Biotech Bear 3x Shares is up 9.2%, or $5.53 to $65.86.

10:00 EDT Small Cap Bear 3x rises 9.7% - Small Cap Bear 3x is up 9.7%, or $4.47 to $50.35.

09:47 EDT Direxion Daily Semiconductor Bull 3X Shares falls -9.3% - Direxion Daily Semiconductor Bull 3X Shares is down -9.3%, or -$1.54 to $15.07.

09:47 EDT PROG Holdings falls -11.6% - PROG Holdings is down -11.6%, or -$2.79 to $21.20.

09:47 EDT Debt Resolve rises 7.5% - Debt Resolve is up 7.5%, or $4.21 to $60.61.

09:43 EDT Lytus Technologies Holdings Ptv Ltd trading resumes

09:37 EDT AeroClean Technologies Inc trading halted, volatility trading pause

09:33 EDT Seven Arts acquires 7.5% interest in Picture Pro - Seven Arts Entertainment is pleased to announce it has acquired a 7.5% interest in a Los Angeles based production company, Picture Pro. The company said, "Picture Pro's team has years of experience, with a primary focus on raising capital for feature films through third party financiers and executive producers. This access to funding will enable Seven Arts to produce larger features and be much more competitive in the film industry." Funding obtained through Picture Pro would be non-dilutive to Seven Arts shareholders as all capital raised would be backed by film assets rather than Company stock

09:28 EDT Advent announces notification of EUR 782.1M project funding from Greek State - Advent Technologies announces that it has received notification from the Greek State for funding under the Important Projects of Common European Interest, or "IPCEI," Hydrogen - Technology, Green HiPo. The notification from the Greek State has been sent to the European Union under the IPCEI framework. Upon EU ratification, total funding of euro 782.1M for Advent's Green HiPo project will be made available over a period of six years, the company stated. The scope of Green HiPo, over the initial period of six years, is to innovatively manufacture fuel cell systems and electrolyser systems. It is intended that the production of these systems will take place in Greece in the region of Western Macedonia. Dr. Vasilis Gregoriou, Advent Chairman and CEO, stated, "Today is a milestone day for Advent but also for Greece and Europe. Green HiPo will catalyse a sea-change of operational events within Advent while the project is implemented. Our application was initially submitted in April 2021, and the process for review and due diligence by the EU has been thorough. We have been clear and focused throughout the process, with the conviction that Advent's Green HiPo project will be instrumental in hydrogen generation and clean energy production. Green HiPo demonstrates the commitment by Greece and the EU to rapidly decarbonize power production and to move forward to energy security and independence with hydrogen technologies playing a crucial role."

09:22 EDT Alkaline Water teams on 'Direct-Store-Delivery' with Dayton Heidelberg - The Alkaline Water is pleased to announce a new Direct-Store-Delivery partnership with Dayton Heidelberg Distributing and Heidelberg Distributing of Northern Kentucky. Heidelberg will distribute Alkaline88( products throughout Ohio and Kentucky as the Company's DSD network continues to grow in strategic markets around the country. "As our existing DSD network continues to exceed expectations and drive brand growth, we are pleased to announce Alkaline88's strategic partnership Heidelberg Distributing in Ohio and Kentucky," said Frank Lazaran, President and CEO of The Alkaline Water Company. "Heidelberg has over 80 years of experience and provides service to approximately 26,000 retailers throughout Ohio and Kentucky which have a combined population of approximately 16 million people. This is a region of the country where we see great potential to continue to gain market share. As our sales team gains more retail doors in the region, having a premier DSD partner like Heidelberg boosts our initial product rollout and will enhance our brand presence in stores. This partnership will bear fruit almost immediately as we continue to add new major retail clients in the region.

09:17 EDT CBTX, Allegiance Bancshares announce FDIC approval of merger of equals - Allegiance Bancshares (ABTX) and CBTX (CBTX) jointly announced receipt of regulatory approval from the Federal Deposit Insurance Corporation, which follows the recent approval from shareholders of both companies. The merger remains subject to the receipt of regulatory approvals from the Board of Governors of the Federal Reserve System and the Texas Department of Banking. The companies expect to close the merger in the third quarter after receipt of such approvals and the satisfaction of other customary closing conditions.

09:14 EDT Hasbro announces investor day on October 4 to outline new CEO's strategic plan - Hasbro issued a letter to shareholders following its 2022 annual meeting of shareholders that states in part: "Following our 2022 Annual Meeting of Shareholders, on behalf of the entire Board and management team, we want to thank you for your investment, continued support, extensive engagement and constructive feedback. We have heard your perspectives, including around shareholder returns, how we make investments in the business and our ongoing approach to Board refreshment. While we are excited about and confident in Hasbro's future, we also know we have important work ahead of us. With the Board's support, our CEO, Chris Cocks, is moving forward with the refinement of Hasbro's long-term strategy, which includes actions to drive meaningful change by focusing on fewer, bigger opportunities, profitably growing our world-class portfolio of brands and amplifying our industry-leading gaming portfolio. As Chris has emphasized, critical to this change will be putting the consumer at the center of everything we do, with a spotlight on games, multi-generational play and entertainment and creating direct relationships with our fans. As the Board works with Chris on this plan, we will actively incorporate the feedback we have received over this past proxy season to help him shape the future of Hasbro and enhance the value we deliver to our shareholders. We will continue engaging with you to solicit feedback, and you can look forward to Chris and the management team outlining our path ahead at our Investor Day on October 4... We look forward to a continued dialogue, which will be critical to our sustained success." Reference Link

09:13 EDT Rubric Capital says Radius board aware of other shareholders' concerns - Rubric Capital Management , an investment advisor whose funds and accounts collectively own approximately 14.62% of the common stock of Radius Health sent a letter to Radius' Board of Directors. Dear Members of the Board of Directors : "I am writing you on behalf of Rubric Capital Management LP , whose managed funds and accounts collectively own approximately 14.62% of the common stock of Radius Health . In light of the back-and-forth commentary of the ongoing proxy contest between the Company and the Velan-Repertoire group, we felt compelled to write this letter in response to the Company's assertion that the activists are engaging in this process "presumably for the short-term benefit of two stockholders whose combined beneficial ownership is approximately 5% of our Company." After this letter it should be clear to the Board that other shareholders with significant holdings have serious concerns about the corporate governance at Radius.

09:11 EDT American International subsidiary receives pharmacy license with TSBP - American International announces that its subsidiary, EPIQ Scripts has received a pharmacy license from the Texas State Board of Pharmacy, TSBP. In addition to obtaining a pharmacy license from the TSBP, EPIQ Scripts has also obtained its National Provider Identifier number and is now a member of the National Council for Prescription Drug Programs, a standards development organization. EPIQ Scripts plans to operate as an online mail-order compounding pharmacy, with a specific target to service and support telehealth and telemedicine companies, and their respective customers and patients, that have been rapidly entering into the market. "I am extremely pleased with the accomplishments and significant progress EPIQ Scripts has made in such a short period of time, since officially launching earlier in February," commented Jacob Cohen, President and CEO of AMIH, who continued, "In just a little over three months, EPIQ Scripts has assembled a fully equipped, staffed and operational pharmacy location occupying approximately 3,000 sq. ft., submitted its application with the Utilization Review Accreditation Commission, obtained its pharmacy license from the Texas State Board of Pharmacy, become a member of the NCPDP, and received its National Provider Identifier number. This has set the stage to allow EPIQ Scripts to focus on its business development and further its expansion initiatives into additional states across the U.S."

09:09 EDT Rockley customer begins evaluation program using its sensing technology - Rockley Photonics announced that one of its tier-1 consumer wearables customers has begun an evaluation program using Rockley's photonics-based sensing technology, which was recently shipped to the customer. Under the evaluation program, Rockley's comprehensive non-invasive biomarker measurement solutions will be assessed for potential integration into the customer's future wearable products. The tier-1 customer adds to Rockley's growing list of global consumer electronics manufacturers to receive shipments of Rockley's VitalSpex Pro technology, which is expected to enable the non-invasive measurement of alcohol, glucose, and lactate from a wrist-worn device.

09:08 EDT Fat Brands, Buffalo's Express to arrive in Tampa - FAT Brands, parent company of Fatburger, Buffalo's Express, and 15 other restaurant concepts, is expanding upon its Florida growth pipeline with a 4-store franchise development deal in Tampa in partnership with Whole Factor Inc. The Fatburger and Buffalo's Express Tampa locations are set to open over the next three years. Whole Factor is also currently developing ten Fatburger and Buffalo's stores in Orlando over the next six years with the first location scheduled to open near the end of 2022. "We see Florida as a strong growth market for Fatburger and Buffalo's Express and are pleased to have a partner like Whole Factor to bring 14 locations to the state over the next several years," said Taylor Wiederhorn, Chief Development Officer of FAT Brands. "We continually hear from our fans that they are eager for us to open in Florida, so we hope that they are just as excited as we are now that we are not only coming to Orlando, but also Tampa."

09:07 EDT Professional Diversity partners with Recruiter.com - Professional Diversity Network (IPDN) announces its partnership with Recruiter.com (RCRT), a recruiting software and on-demand services company. Through the partnership, PDN and Recruiter.com will jointly distribute job postings and co-market their diversity recruitment offerings. PDN will serve jobs to Recruiter.com's newly launched, diversity-specialized career community, and offer an upgrade for the job posts across Recruiter.com's career communities. "Professional Diversity Network, Inc. is proud to partner with Recruiter.com to help employers access diverse talent," said Adam He, CEO of PDN. "As a top diversity recruitment platform offering a wide range of recruitment solutions, PDN provides a unique and scalable talent acquisition channel for reaching diverse candidates. PDN's collaboration with Recruiter.com will help distribute job postings across Recruiter.com's career communities for added exposure. We are proud to choose the Official Partner of Recruiter.com's new career community for Diversity professionals." Said He.

09:06 EDT Willis Towers Watson partners with One Concern for climate resilience score - WTW announced a strategic alliance with One Concern, a climate analytics company. The two companies are providing the U.S. insurance market with One Concern Resilience Score to facilitate a better understanding of dependency risk and accelerate the adoption of parametric insurance. The One Concern Resilience Score indicates the vulnerability a business has concerning downtime arising from the fragility of the infrastructure a business relies upon, such as the power grid, transportation infrastructure, and related community areas, in addition to direct property damage. One Concern's analytics will support and augment WTW clients' risk analyses and decision-making regarding specific mitigation steps, costs, and benefits, including alternative risk transfer mechanisms.

09:06 EDT ShiftLeft in strategic Investment from and go-to-market deal with Wipro - ShiftLeft, an innovator in automated application security testing, announced an investment from and go-to-market partnership with Wipro Ventures With this investment, Wipro, with its strong global presence, will become a key partner in ShiftLeft's continued growth. The ShiftLeft CORE platform combines both static application security testing and software composition analysis solutions to create a unified view of potential application vulnerabilities. As a modern, cloud-native application built to make both application security and development teams' lives easier, ShiftLeft scans whole applications in minutes, allowing customers to scan their code with every software release. ShiftLeft's unique Code Graph technology combines, analyzes and prioritizes SAST and SCA results to map actual data flows through applications to validate "attackability" - indicating whether security flaws can be reached by attackers. This innovative approach gives ShiftLeft the lowest false positive rate in the industry compared to other accepted OWASP application security benchmarks. "Wipro has repeatedly demonstrated that it is a leader when it comes to bringing new technological innovations to customers," said Manish Gupta, CEO, ShiftLeft. "Equally important, Wipro is a 'shift left' organization leading the way in empowering developers to improve code security throughout the software development cycle. "ShiftLeft makes it intuitive for Wipro's hundreds of Cybersecurists and tens of thousands of software developers to build security into the DNA of every software release. With this new partnership with Wipro, customers from various sectors, including healthcare, industrials, manufacturing, retail, hospitality and government, will be able to deploy and operate ShiftLeft.

09:05 EDT eXp World appoints Ansari as CIO, Pareja as President of Affiliated Services - eXp World has appointed Shoeb Ansari as Chief Information Officer, CIO, of eXp World Holdings and Leo Pareja as President of Affiliated Services for eXp Realty. Ansari will lead software engineering, product management, information technology, product launch, project management, data services and innovation for eXp World Holdings and its companies. Before joining eXp Realty, Ansari served as the Chief Technology Officer for RealPage. As President of Affiliated Services, Pareja will oversee all eXp Realty products and services such as mortgage, title, escrow and lead-generation platforms. Pareja co-founded one of the largest private lending companies on the East Coast of the U.S. and most recently co-founded a fast-growing MLS technology vendor.

09:04 EDT Luokung Technology acquires HDtraffic, builds data middle station with OEM - Luokung Technology has closed the acquisition of Beijing Hongdajiutong Technology - HDtraffic -, a big data service provider for intelligent transportation and connected vehicles in China. HDtraffic has established a joint development team with a commercial vehicle OEM to build a Data Middle Station, an enterprise-level platform of comprehensive data capability, which includes data collection, exchange, sharing, integrating, organizing, processing, modeling, analyzing, management, governance, service and application, and has begun providing commercial services to the OEM. In 2021, the OEM reported annual sales of approximately 700,000 commercial vehicles, ranking second in commercial vehicle sales in China for the year. The joint development team will focus on the development of products such as the Internet of Vehicles big data analysis system and services related to typical application scenarios for commercial vehicles.

09:03 EDT CleanSpark acquires contract for mining machines, partners with TMGcore - CleanSpark announced it has taken over an existing purchase contract for 1800 Antminer S19 XP units as it continues to expand its infrastructure. Once fully deployed, the machines are expected to add over 252 petahashes per second, PH/s, to the Company's bitcoin mining capacity. Further, the company announced a partnership with TMGcore, a global leader in the development, commercialization and deployment of high performance computing solutions, which includes ASIC mining applications, to expand its immersion-cooled infrastructure for sustainable mining. As per the acquired contract, the Antminer S19 XP machines will start arriving at CleanSpark's facilities sometime in August, and shipping will continue through the next six months. The contract was brokered by Cryptech, a leading US-based supplier of cryptocurrency mining machines and longtime partner of the Company. "We were able to secure the contract at an exceptional price because of our strategic relationships and the unique circumstances that current market conditions have created," said CEO Zach Bradford. "Our infrastructure-first approach has given us substantial opportunities in the face of ever-changing market conditions, ultimately positioning us to deliver incredible value to our shareholders as we continue the important work of securing the bitcoin blockchain." The new partnership with TMGcore includes 257 units of TMGcore's proprietary immersion-cooled tanks that are specifically designed to improve the performance of mining machines while substantially decreasing their failure rates over long term use.

09:02 EDT Embark Technology says NHTSA ADS crash data shows perfect safety record - Embark Trucks emerged with a perfect safety record in new data reported by the National Highway Traffic Safety Administration yesterday. The agency released the crash data collected from Automated Driving System and Advanced Driver Assistance System companies under a Standing General Order issued in June 2021. Embark reported zero crashes since NHTSA began collecting data last year, and has never had a NHTSA-reportable crash in its history. NHTSA issued the SGO to evaluate whether the manufacturers of ADS and ADAS systems are meeting their statutory obligations to ensure that their vehicles and equipment are free of defects that pose unreasonable risks to motor vehicle safety. Notably, the SGO requires developers of ADS, such as Embark, to report all public road crashes to NHTSA while ADAS developers are only required to report more severe crashes such as those resulting in hospitalization or death. Since its founding in 2016, Embark has never been involved in a NHTSA- or FMCSA-reportable crash. This impeccable safety record is made possible by Embark's high operational standards and technical capabilities such as Vision Map Fusion. NHTSA's crash data released yesterday lists 3 crashes involving autonomous trucks across the industry over the past year out of 130 total reported ADS-involved crashes across all vehicle types, showing the industry's strong progress.

08:53 EDT Camber Energy redeems Preferred Shares - Camber Energy is pleased to announce that on June 15, 2022 it redeemed 2,636 shares of Series G Preferred Stock, which were previously issued by the Company on December 31, 2021 as part of a financing commitment from an institutional investor. The 2,636 Series G Shares were associated with a promissory note issued by the investor in favor of the Company in the principal amount of $23,750,000, due June 30, 2022, and the Company exercised its right to redeem the shares and cancel the promissory note. The other two promissory notes issued by the investor in favor of the Company remain outstanding and the Company has the right to redeem the Series G Shares associated with such notes.

08:50 EDT Vivakor to acquire Silver Fuels Delhi and White Claw Colorado City - Vivakor announced that it has signed a definitive agreement to acquire Silver Fuels Delhi and White Claw Colorado City. If consummated, the acquisitions will enable Vivakor to enter a synergistic segment of the energy industry with the combination of a crude oil gathering, storage, and transportation facility, which feature long-term ten year take or pay contracts. In 2021, SF Delhi generated $33M in revenue and positive operating cash flow. The acquisition is structured as a Membership Interest Purchase Agreement, or MIPA, with the owners of SF Delhi and WCCO, Jorgan Development and JBAH, to sell 100% of the membership interests of SF Delhi and WCCO to Vivakor for total consideration of approximately $37.4M, subject to post-closing adjustments. The consideration to be paid by Vivakor under the MIPA consists of shares of Vivakor common stock in an amount equal to 19.99% of the total amount of issued and outstanding shares of Vivakor common stock immediately prior to closing, Vivakor promissory notes, and Vivakor's assumption of certain liabilities. The acquisitions are anticipated to be completed within thirty days, subject to customary closing conditions. SF Delhi owns and operates a crude oil gathering, storage, and transportation facility located on approximately 9.3 acres near Delhi, Louisiana. For a period of 10 years, SF Delhi is, under existing crude oil supply agreements with White Claw Crude, guaranteed a minimum gross margin under a take or pay contract. At present, SF Delhi is gathering approximately 1,400 to 1,700 barrels of crude oil on a daily basis. WCCO owns a 120,000 barrel oil storage tank, in the heart of the Permian Basin, located near Colorado City, Texas. The storage tank is presently connected to the Lotus pipeline system and Vivakor intends to further connect the tank to the Medallion and Wolf pipeline system if the acquisition is successfully completed. Under the terms of an already existing agreement, White Claw Crude has agreed to lease the oil storage tank for a period of 10 years. As with SF Delhi, WCCO would provide Vivakor with the infrastructure to blend and sell oil which has been recovered via Vivakor's RPC machine from tank bottom sludge and contaminated soil which exists in the Permian Basin.

08:49 EDT Evofem's Phexxi shows 99% pregnancy prevention in Phase 3 clinical trial - Evofem announced results of a post hoc analysis of the registrational Phase 3 AMPOWER trial investigating the ability of Phexxi to prevent pregnancy. In the analysis, Phexxi prevented 99% of pregnancies per act of intercourse. This was based on 101 pregnancies over 24,289 acts of intercourse with typical use in 1,182 women. Earlier this year, the Journal of Sexual Medicine published a post hoc analysis of an exploratory endpoint showing that 88.7% of women using Phexxi in AMPOWER improved or maintained their sex life. Additionally, last month, Evofem presented a post hoc analyses at the American College of Obstetricians and Gynecologists annual clinical and scientific meeting showing that incidences of urinary tract infections in women who used Phexxi in AMPOWER were less compared to the general population: 5.8% vs 11.0%. The FDA approved Phexxi in May of 2020 based on the registrational AMPOWER trial.

08:48 EDT Reserve Bank of India lifts business restrictions imposed on Mastercard - The Reserve Bank of India announced: "In view of the satisfactory compliance demonstrated by Mastercard Asia / Pacific Pte. Ltd. with the Reserve Bank of India circular dated April 6, 2018 on Storage of Payment System Data, the restrictions imposed, vide order dated July 14, 2021, on on-boarding of new domestic customers have been lifted with immediate effect." Reference Link

08:46 EDT Blockchain Intelligence Group launches NFT Explorer - Blockchain Intelligence Group announced the launch of NFT Explorer, a risk and investigation solution for NFTs, built on the QLUE data analytics platform. Development of the new NFT Explorer core capabilities relied on client feedback and work with expert collaborators across financial, tech, and law enforcement sectors. One such collaborator was Los Angeles County Sheriff's Department Detective Tony Moore. Core capabilities include: Comprehensive token tracking on the ERC-721 standard, including market cap and 24-hour volume; Explorer function for ERC-271, displaying NFTs by collection, along with lists of token traits, including name, image, token owner, and associated transactions; Ability to perform investigations that include NFT transfers; Additional blockchains that support NFTs are slated for integration.

08:44 EDT Ebix down 21% after short seller Hindenburg warns of solvency risk

08:43 EDT AcuityAds announces results of Annual General Meeting - AcuityAds Holdings announced that, at its annual and special meeting of shareholders held earlier, all director nominees were elected as directors of the Corporation. In addition, the other two items of business at the Meeting, being the re-appointment of auditors of the Corporation and approval of the Advance Notice By-Law of the Corporation, were also approved.

08:42 EDT Super League Gaming engages MZ Group to lead investor relations - Super League Gaming has engaged MZ Group to lead a comprehensive strategic investor relations and financial communications program across all key markets. MZ Group will work closely with Super League Gaming management to develop and implement a comprehensive capital markets strategy designed to increase the Company's visibility throughout the investment community. The campaign will highlight how Super League is building and operating the next generation gaming platform for the metaverse with a network of games, monetization tools and content channels that empowers developers, energizes players and entertains fans. Its 360-degree solution to introduce advertisers to engaged gamer communities is highly compelling for brands looking to reach the elusive Gen Z audience while delivers maximum campaign objectives.

08:41 EDT eMagin awarded $2.5M US Army contract for OLED microdisplay prototype project - eMagin Corporation announced it has been awarded a $2.5M contract from the U.S. Army for a high-brightness, full-color OLED microdisplay prototype project, including manufacturing process technologies. The prototype will be used in AR systems that provide both sensor and tactical data to soldiers, thereby enhancing situational awareness and mobility in a range of military applications. "We are honored that the Department of Defense has recognized eMagin's OLED manufacturing and technical capabilities and appreciate the grant award, which will support our continuing efforts to provide a U.S. supply chain solution for these critical military components," said Andrew Sculley, CEO of eMagin Corporation. "eMagin is the sole U.S. manufacturer of OLED microdisplays and we have proudly supplied to U.S. defense programs of record since 2006."

08:40 EDT Ormat announces commercial operation of 5 MW/20 MwH Tierra Buena BESS - Ormat Technologies announced the commercial operation of the 5 MW/20 MWh Tierra Buena Battery Energy Storage System, Tierra Buena BESS. The Tierra Buena BESS will provide local resource adequacy, to two Community Choice Aggregators, Redwood Coast Energy Authority and Valley Clean Energy, at 2.5 MW each, under 10-year agreements. In addition, the facility will provide ancillary services and energy optimization through participation in merchant markets run by the California Independent System Operator, CAISO. The Tierra Buena BESS is Ormat's third operating BESS facility in California, which increases Ormat's energy storage portfolio to 88 MW/196 MWh. The facility will connect to the adjacent PG&E distribution circuit and is expected to generate revenues beginning in July 2022.

08:38 EDT GBS Inc. enters into exclusivity agreement with Intelligent Fingerprint - GBS announced that it has executed an exclusivity agreement with Intelligent Fingerprinting in respect of GBS's proposed acquisition of IFP. "By potentially combining Intelligent Fingerprinting's leadership position as a revolutionary point of care fingerprint sweat-based drug screening technology with our saliva-based glucose biosensor platform and manufacturing expertise, GBS would be able to serve a wider spectrum of patients at point of care across global diagnostic markets," stated Dr. Steven Boyages, Interim Chief Executive Officer. "We believe that this acquisition, if consummated, could provide us with a clear opportunity to build long-term shareholder value, accelerate revenue growth for both parties through an expanded portfolio of tests, and allow GBS to further solidify its leadership as a developer of rapid non-invasive diagnostic solutions outside of saliva while accelerating revenue growth." The transaction, if consummated, would allow GBS to further solidify its leadership as a developer of rapid non-invasive diagnostic solutions outside of saliva, while also accelerating revenue growth through an expanded portfolio of tests. Through the proposed transaction with IFP, GBS would gain access to the full IFP product portfolio, IFP's current customer base and the ISO 13485 manufacturing facility in the United Kingdom as GBS continues to develop its own facility at the University of Newcastle, Australia. The Exclusivity Agreement provides GBS with the exclusive right until December 31, 2022, to evaluate and negotiate a transaction to acquire IFP or its assets. In consideration for this exclusivity, GBS has entered into a Bridge Facility Agreement through which GBS will provide IFP with an unsecured term loan facility in the amount of $500,000, which is repayable on the earliest of the termination of exclusivity under certain circumstances, or December 31, 2022.

08:37 EDT Navitas says GaNFast power ICs power Anker's 100W fast charger - Navitas Semiconductor has announced that its GaNFast power ICs with GaNSense technology power Anker Innovation's new 100 W fast charger. Both the GaNFast ICs and the Anker 736 Charger multi-port charger are CES Innovation Award Honorees, with the Anker 736 officially launched to the market in May 2022. Compatible with USB 3.0 PD PPS and Qualcomm Quick Charge 3.0, and measuring only 67 x 31.5 x 56.97 mm the charger achieves a power density of 0.83 W/cc and can deliver a 50% charge to an Apple MacBook Pro 16 2021 in just 40 minutes.

08:34 EDT Biote names Ross McQuivey, M.D CMO, effective June 10 - Biote announced that it has appointed Ross W. McQuivey, M.D., as its Chief Medical Officer, effective June 10, 2022. Dr. McQuivey will be responsible for leading continuing clinical research efforts and publications. The Company also expects that he be instrumental in expanding the Biote Method to mainstream medicine. Dr. McQuivey brings to Biote more than 20 years of medical and scientific leadership in the healthcare industry, with management experience in research and development, medical affairs, as well as regulatory and quality control. He has published over a dozen peer-reviewed journal articles, abstracts and poster presentations, and has lectured extensively in the United States and internationally.

08:34 EDT PepGen announces anticipated upcoming milestones - PGN-EDO51: PepGen anticipates presenting safety and tolerability, pharmacokinetic and exon 51 skipping data from a Phase 1 HNV trial of PGN-EDO51 for the treatment of DMD by the end of 2022.PGN-EDODM1: PepGen anticipates submitting an IND application for PGN-EDODM1 to the U.S. Food and Drug Administration in the first half of 2023 to initiate a Phase 1/2 clinical trial in myotonic dystrophy type 1 patients. Additional Pipeline Assets: PepGen expects to report non-human primate exon skipping data for PGN-EDO53, the company's second DMD program for the treatment of exon 53 skipping amenable patients, in the second half of 2022. Additionally, the Company plans to nominate candidates for PGN-EDO45 and PGN-EDO44, which target the exon 45 and exon 44 DMD patient populations respectively, in the second half of 2022.

08:33 EDT Global Cord Blood says purported extraordinary general meeting is invalid - Global Cord Blood noticed that on June 3, Blue Ocean Structure Investment - the "Petitioner" - issued a notice which purported to convene an extraordinary general meeting - EGM - of the company to be held on June 16. The company's position is that this EGM has not been validly convened. The purported EGM was convened without the requisite threshold of 75% having been met. The company considers it inappropriate to comment on the issues tabled for the purported EGM at this juncture. These issues are currently the subject of live proceedings in the Cayman Islands and the British Virgin Islands. The company looks forward to providing investors with an update as and when it is appropriate to do so.

08:32 EDT 22nd Century appoints Kinsman as CFO - 22nd Century Group announced the appointment of R. Hugh Kinsman as Chief Financial Officer. Kinsman is currently CFO of GVB Biopharma, which 22nd Century acquired effective May 13, 2022. Kinsman has experience as a senior executive in roles ranging from acting CFO of a publicly-traded battery manufacturer with operations in the U.S., Switzerland, and Italy to the CFO of West World Media.

08:30 EDT Digital Health Acquisition Corp trading resumes

08:25 EDT Cuentas founder Maimon purchases 32,850 shares of company stock - Cuentas announces announces that its co-founder and Executive Chairman of the Board of Directors, Mr. Shalom Arik Maimon purchased 32,850 shares of CUEN on the open market.My personal investment in CUEN as a founder of the company shows that I have complete faith in the future of Cuentas" said Arik Maimon, Co-Founder & Executive Chairman of Cuentas."I sincerely believe that Cuentas' shareprice is undervalued and with the current economic situation and inflation, Cuentas continues to provide important benefits and significant savings to its cardholders in the USA. I believe that Cuentas is in the right place and right time to benefit from changing digital financial services," added Maimon and Executive Chairman of the Board of Directors, Mr. Shalom Arik Maimon today purchased 32,850 shares of CUEN on the open market."My personal investment in CUEN as a founder of the company shows that I have complete faith in the future of Cuentas" said Arik Maimon, Co-Founder & Executive Chairman of Cuentas."I sincerely believe that Cuentas' shareprice is undervalued and with the current economic situation and inflation, Cuentas continues to provide important benefits and significant savings to its cardholders in the USA. I believe that Cuentas is in the right place and right time to benefit from changing digital financial services," added Maimon

08:23 EDT Genetic Technologies announces completion of Budget Impact Model - Genetic Technologies announced the completion of an independently developed and validated customizable Budget Impact Model, which demonstrates significant health and economic benefits directly attributed to the implementation of geneType Breast Cancer Risk Assessment Test. Breast cancer risk stratification based on BRCA and other hereditary and familial factors is applicable to only 10% of women, with the consequence being that 85% of breast cancers are diagnosed as sporadic, with no prior warning to the patient. There is an urgent clinical and economic need for an all-inclusive risk stratification tool to enable all women being screened to understand their risk for breast cancer in the near and mid-term. In women diagnosed with breast cancer, only 15% are high risk identified by BRCA, hereditary, or familial factors. The remaining 85% are sporadic with uncertain risk, and thus an urgent clinical and economic need for a comprehensive risk stratification tool that will enable all women being screened to understand their risk for breast cancer and undergo appropriate management. Key Benefits attributed to the geneType Breast Cancer Risk Assessment Test: Potential to deliver $1.4 billion annual saving represents 3.6% of the total annual US Payer costs for breast cancer treatment; Significant savings of $73 per patient per year; An overall increase in women being health screened, from 69% to 74%; Early-stage cancer detection would be increased from 57% to 67%; Interval cancers drop from 14.8% to 8.8%, a substantial 40.5% reduction. The BIM was independently developed and validated by ALVA10, whose mission is to create an economic ecosystem that pulls technology into healthcare, aligning effective healthcare solutions to Payer economics. The BIM illustrates the clinical pathways patients would experience and the economic implications of commercialization and utilization of a test or device. The main finding of the BIM is the potential for US Payers to reduce the annual costs of breast cancer treatment by $1.4 billion.

08:23 EDT Bakkt to join Russell 3000 Index - Bakkt announced it is set to join the broad-market Russell 3000 Index at the conclusion of the 2022 Russell indexes annual reconstitution, effective after the U.S. market opens on June 27, according to a preliminary list of additions posted on June 3.

08:22 EDT Global Blood Therapeutics partners with NFL's Tevin Coleman for SCD awareness - Global Blood Therapeutics announced a new partnership with New York Jets running back Tevin Coleman and his wife, Akilah, whose 4-year-old daughter lives with sickle cell disease, with the goal of educating, inspiring, and raising awareness about SCD - especially among other parents and caregivers. Starting today, just ahead of World Sickle Cell Day on June 19, 2022, which also happens to be Father's Day, the Colemans will be sharing their family's story as part of Sickle Cell Speaks, GBT's education campaign that highlights authentic stories of those living with sickle cell to raise awareness and dispel misconceptions about the disease.

08:19 EDT Principal Solar says 'now is the perfect time' to spin off oil, gas operations - Principal Solar, released an update to its shareholders from K. Bryce Toussaint, CPA, MBA, the Company's Chairman and CEO. The letter said, "Oil and natural gas prices remain near their highest levels in 14 years. According to sources such as The Goldman Sachs Group, Standard & Poor's, and the Energy Information Administration, the market outlook is expected to remain strong through 2023 and beyond. Consequently, we believe now is the perfect time to spin off our oil and gas operations into a new, stand-alone, publicly-traded company hyper-focused on the execution of our high-growth strategic plan to employ cutting-edge, green, and low-impact technology to extract more oil and gas from abandoned and orphaned fields. To that end, Principal's board of directors has approved a plan to begin structuring the Company's E-3 Petroleum subsidiary into a separate entity, which will consist of Principal's oil and gas investments in Texas and Oklahoma as well as its licensed environmentally friendly extraction technologies. The new company will be led by Principal's current COO, Anthony Lerner, who will be supported by a dedicated team of managers and advisors with deep experience in oil and gas. We believe there are myriad benefits to be realized through this activity. Both companies will be free to focus on their respective core businesses; Principal will be better able to quickly react to changes in the renewable energy sector, and E-3 will be better able to capitalize on increases in oil and gas commodity prices. As separate entities, there may be the potential to offset dilution from past convertible notes that could have negatively impacted PSWW's share performance. And last, but certainly not least, we hope to reward Principal's loyal shareholders for staying the course with us as we navigate today's challenging public markets. Though specifics have yet to be determined, at least initially, we expect that E-3 will be 100% owned by Principal's shareholders, and our plan is to fund the new company through an S-1 registration statement. PSWW's recent qualification of its second Reg A+ offering stands to accelerate both companies' expansion plans over the next twelve months. I feel strongly that burgeoning energy prices fueling a focused, independent E-3 Petroleum offers the greatest potential to deliver superior returns to our shareholders. Additionally, I am scheduled to be interviewed this week by Mr. Everett Jolly, the founder and CEO of Stock Day Media. During this interview, I will be discussing the E-3 spin-off in further detail, as well as each company's current market opportunities. The interview will be aired next week."

08:15 EDT Star Equity's KBS Builders signs $4.2M contract to build workforce housing - Star Equity Holdings announced that its KBS Builders business has signed a $4.2M contract to manufacture 60 modules for the construction of eight new multi-family buildings as part of a workforce housing development on the island of Nantucket in Massachusetts. This development will help improve Nantucket's availability of affordable housing, a longstanding challenge facing the island. Production of two of the eight buildings has already commenced, and production of the remaining buildings is expected to continue into the fall of 2022. Rick Coleman, Chief Executive Officer of Star Equity, noted, "This high-visibility project on Nantucket marks the second large-scale commercial project KBS has won thus far in 2022. KBS's sales team continues to do great work with booked backlog now extending into November, and the entire KBS team is making great strides toward achieving our production, quality, and profitability goals."

08:15 EDT Comera Life Sciences appoints Michael Campbell CFO - Comera Life Sciences Holdings announced the appointment of Michael Campbell as Executive Vice President and Chief Financial Officer. He had served as interim Chief Financial Officer since April 13 and will continue to oversee Comera's finance operations, including accounting and reporting, corporate tax, treasury and investor relations.

08:14 EDT Panbela Therapeutics closes acquisition of CPP - Panbela Therapeutics announced the closing of its acquisition of Cancer Prevention Pharmaceuticals, CPP, a private clinical stage company developing therapeutics to reduce the risk and recurrence of cancer and rare diseases, for a combination of stock and future milestone payments. The combined entity will focus on maximizing its extensive pipeline addressing an estimated aggregate $5B market opportunity for the areas of initial focus: familial adenomatous polyposis, first-line metastatic pancreatic cancer, colorectal cancer prevention and ovarian cancer. "Closing this transaction achieves our goal of creating a diversified pipeline with an ability to hit multiple targets, four clinical stage assets, two of which are late-stage registration assets, thereby increasing the potential of the combined company," said Jennifer Simpson, PhD, MSN, CRNP, President & Chief Executive Officer of Panbela. "Together, our capabilities will have an even greater chance to help more patients. The addition of CPP is an excellent fit that we feel produces substantial shareholder value."

08:12 EDT Ebang announces intention to obtain MSO License from Hong Kong Customs - Ebang International announced that the Company intends to obtain a Money Service Operator License, MSO License, from the Hong Kong Customs and Excise Department. If and when obtained, the MSO License will allow the Company to operate a money service in Hong Kong as either a money changing service and/or a remittance service in Hong Kong. This decision to pursue the MSO License represents another major strategic initiative of the Company in further developing its global collection and payment business following the successful acquisition of Compass Global Holdings, which acquisition enabled the Company to obtain an Australian Financial Services License from the Australian Securities and Investments Commission, ASIC. Dong Hu, Chairman, Chief Executive Officer and Chief Financial Officer of the Company, commented, "Australia is one of the fastest-growing financial derivatives trading markets in the world, with a mature and sound supervision and management mechanism. The successful acquisition of Compass allows us to have access to the foreign currency market resources, expand the diversification of our products and diversify our services. Aiming to reduce the impact of cryptocurrency price volatility on cryptocurrency companies like us, we have decided to further optimize our strategic plan to develop and operate a global collection and payment business. As a major financial market in Asia, Hong Kong is at the forefront of the world in terms of the maturity of regulations, the perfection of public transactions, the scale of asset management and the richness of financial products, and it is the preferred platform for many investors."

08:10 EDT Enphase Energy expands IQ8 microinverter deployments in New York - Enphase Energy announced that installers of Enphase products in New York have seen growing deployments of Enphase Energy Systems powered by IQ8 Microinverters following the product's launch in North America late last year. IQ8 Microinverters paired with Enphase's industry leading IQ Batteries give homeowners more energy security as increasingly common heat waves and other natural disasters strain the grid. Enphase's IQ8-based systems can provide Sunlight Backup functionality during an outage, even without a battery.

08:09 EDT Tenaya finishes 'build-out' of Genetic Medicines Manufacturing Center in CA - Tenaya Therapeutics announced that it has completed the build-out and operational launch of its Genetic Medicines Manufacturing Center in Union City, California. Tenaya is advancing a pipeline of therapeutic candidates, including several adeno-associated virus AAV gene therapies, for the potential treatment of both rare and prevalent forms of heart disease. Tenaya's Genetic Medicines Manufacturing Center located in Union City, CA. Tenaya made an early, strategic commitment to internalize several core capabilities to optimize the safety, efficacy, and supply of our product candidates on behalf of patients. With today's announcement we have made a big leap forward on that commitment by establishing end-to-end in-house manufacturing capabilities for our pipeline of AAV-based gene therapies," said Faraz Ali, Chief Executive Officer of Tenaya. "The operational launch of Tenaya's Genetic Medicines Manufacturing Center represents an important milestone as we prepare to advance our robust pipeline of potentially first-in-class cardiovascular therapies into initial clinical studies."

08:08 EDT Olink announces partnership with Erasmus Medical Center in Rotterdam - Olink Holding announced that the Human Genomics Facility of the Erasmus Medical Center in Rotterdam has adopted the Olink technology, becoming the first Olink Explore certified laboratory in the Netherlands. The Rotterdam Human Genomics Facility houses one of Europe's largest high-throughput genomics facilities, offering genomics services to global customers. This partnership offers a new opportunity to combine several layers of multi-omics approaches to unravel mechanisms of human disease biology and accelerate development of novel therapies.

08:07 EDT Kroger CFO sees 'total shareholder returns of 8-11% over time' - Comments from CFO Gary Millerchip: "Our relentless focus on executing our strategy and sustained food at home trends led to a strong first quarter. The Kroger team is effectively navigating a dynamic retail environment. Our diverse and resilient business model gives us confidence to raise our full-year guidance. We now expect identical sales without fuel to be in the range of 2.5% to 3.5%, adjusted FIFO operating profit of $4.3 billion to $4.4 billion, and adjusted net earnings per diluted share to be in the range of $3.85 to $3.95. We remain confident in our ability to deliver sustainable earnings growth and total shareholder returns of 8-11% over time."

08:06 EDT Kroger reports Q1 gross margin 21.6% - Gross margin was 21.6% of sales for the first quarter. The FIFO gross margin rate, excluding fuel, decreased 26 basis points compared to the same period last year. This decrease was primarily attributable to continued strategic price investments and higher supply chain costs offset by sourcing benefits and the cycling of a write-down related to a donation of personal protective equipment inventory from prior year.

08:06 EDT Chipotle tests Mexican Cauliflower Rice at 60 restaurants - Chipotle Mexican Grill announced it is piloting Mexican Cauliflower Rice at 60 restaurants in Arizona, Southern California, and Wisconsin for a limited time. The company's latest plant-based menu innovation is crafted with freshly grilled, riced cauliflower seasoned with the savory spices of Mexican rice.

08:05 EDT AC Immune's Crenezumab does not meet primary endpoints in Alzheimer's study - Overnight, AC Immune "announced results from the Alzheimer's Prevention Initiative Autosomal Dominant Alzheimer's Disease Colombia Trial. The study evaluated the potential of crenezumab, an investigational medicine, to slow or prevent Alzheimer's disease in cognitively unimpaired people who carry a specific genetic mutation which causes early-onset Alzheimer's disease. Numerical differences favouring crenezumab over placebo were observed across the co-primary, multiple secondary and exploratory endpoints, though none were statistically significant. The co-primary endpoints assessed the rate of change in cognitive abilities or episodic memory function, measured by the API ADAD composite cognitive total score and the Free and Cued Selective Reminding Test Cueing Index, respectively. Crenezumab was generally well tolerated during the study and no new safety issues were identified. Further analyses of data are ongoing. Initial data will be presented at the Alzheimer's Association International Conference on August 2, 2022." Shares of AC Immune are down 29.7% in pre-market trading at $2.01.

08:05 EDT Climb Channel Solutions appoints Tim Popovich as president - Climb Channel Solutions promoted Tim Popovich from Executive Vice President of Sales and Operations to President of Climb Channel Solutions North America. Tim was hired in 2003 as a Sales Associate rising through the ranks with 6 additional titles before his promotion to President.

08:04 EDT Digital Health Acquisition to acquire VSee Labs, iDoc Telehealth Solutions - Digital Health Acquisition Corporation announced that it has signed a definitive agreement to acquire VSee Lab, a telehealth software company and iDoc Telehealth Solutions, a neurocritical care and intensive care telehealth provider. The newly merged company will bring together the organizations and leadership teams of San Jose, California-based VSee, and Houston, Texas-based iDoc with the Nasdaq-listed Digital Health public company. Upon closing of the transaction, which is expected to occur in the third quarter of 2022, it is anticipated that the combined company will adopt the corporate name VSee Health, Inc., and will be listed on the Nasdaq Capital Market under the proposed new ticker symbol "VSEE." The transaction is expected to result in a valuation of approximately $110 million for the combined entity. VSee provides a proprietary SaaS platform that enables medical providers to provide telehealth services with end-to-end, HIPPA-compliant encrypted payment solutions with multiple additional real-time integrated and interactive capabilities. Because of its flexibility and security, VSee was selected as exclusive supplier to NASA, and was also recently selected by the Ukraine to customize a telehealth solution, which it accomplished in less than 72 hours. The newly combined company, VSee Health, will integrate iDoc's intensive care and neuro solution as its first module for the VSee software platform, with the goal of adding additional modules in the future. The merger will provide the consolidated company with access to significant additional cash subject to the level of redemptions from Digital Health's public stockholders, that are targeted to be used to expand modules onto the VSee Platform, widening both VSee's and iDoc's customer bases, and for general working capital purposes. The boards of directors of VSee, iDoc, and Digital Health have unanimously approved the proposed transaction. The closing is subject to the approval of VSee's, iDoc's, and Digital Health's stockholders, as well as other customary closing conditions, including Digital Health's registration statement being declared effective by the Securities and Exchange Commission and the expiration or termination of any applicable Hart-Scott-Rodino Act waiting periods. The transaction is expected to close by the end of the third quarter 2022, assuming satisfaction of closing conditions set forth in the parties' definitive agreement.

07:56 EDT Mobiquity Technologies announces roll-out of advertising products - Mobiquity Technologies announced, after being selected by Reflex Finance as its data and programmatic advertising provider for their business to business and direct to consumer brand awareness campaigns, Reflex has decided to roll-out the Mobiquity platform across their portfolio of products. The Reflex native token, $REFLEXV2, is a hyper deflationary reflection token hosted on the Binance Smart Chain. Based on an innovative liquidity generating protocol with additional staking opportunities, it was launched on February 5th, 2022, and paid out over $1 million in reflections in the first 48 hours. As a show of confidence, all the teams' tokens are vested and can never be sold. As such, the team is compensated only in $BUSD reflections.

07:51 EDT Customers Bancorp announces mid-quarter financial update - Consensus Customers Bancorp issued a mid-quarter financial update. Management expects to meet or beat guidance of $4.75-$5.00 Core EPS, excluding PPP, for FY22. Tangible book value per share is expected to exceed $40 by year-end 2022. Return on common equity is expected to be greater than 17% for full year 2022. The company said, "We continue to remain moderately asset sensitive in a rapidly rising interest rate environment."

07:41 EDT Rekor Systems Traffic Management solution selected by Netivei Israel - Rekor Systems announced its joint program launched by Netivei Israel, the national transport infrastructure company of Israel, in collaboration with Israel Living Lab Consortium and the Israel Innovation Authority. The program designates the Rekor One Traffic Management solution as the platform to drive data accessibility and improve traffic congestion and road safety on Israel's main coastal highway. This one-year project is one of the largest initiatives for private-public collaboration in the Israel transportation space to date and will deliver approximately $300,000 in revenue for Rekor.

07:39 EDT CI to purchase 16.8M of its shares with Normal Course Issuer Bid through TSX - CI Financial announced that the Toronto Stock Exchange has accepted its Notice of Intention to make a Normal Course Issuer Bid and Automatic Securities Purchase Plan. CI intends to purchase up to 16,828,703 of its common shares by way of a Normal Course Issuer Bid, through the facilities of the TSX and/or alternative Canadian trading systems or by such other means as may be permitted by the applicable securities regulator. Common shares may be purchased by CI or purchased by a trustee, to satisfy obligations under equity-based compensation or employee share purchase plans for CI. All common shares purchased by CI will be cancelled. The 16,828,703 common shares represent 10% of the total public float for CI . As of June 8 there were 192,356,369 issued and outstanding common shares of CI. It is expected that the purchases under the Normal Course Issuer Bid may commence on June 20, and will terminate on June 19, 2023, or on such earlier date as CI completes its purchases or provides notice of termination. Purchases will be effected through the facilities of the TSX at prevailing market prices, or such other means as may be permitted by the Ontario Securities Commission or Canadian Securities Administrators, and through alternative Canadian trading systems. CI is permitted to purchase up to 191,343 common shares daily, being 25% of the average daily trading volume of the common shares for the six months ended as of May 31, 2022 . CI believes that the market price of the common shares may, at certain times throughout the duration of the Normal Course Issuer Bid, be undervalued based on CI's financial performance and prospects, and accordingly, the Board of Directors are of the opinion that the purchase of common shares is an appropriate use of funds in order to increase shareholder value. Under its current Normal Course Issuer Bid, CI obtained approval to purchase up to 18,194,790 of its common shares, of which CI, the trustee, and non-independent broker purchased 13,758,187 common shares at a weighted average price of $20.53 per common share between June 18, 2021 and June 8, through the facilities of the TSX and alternative Canadian trading systems.

07:41 EDT OverActive Media, TD Bank expand sponsorship with multiyear agreement - OverActive Media (OAM) announced the renewal and expansion of their agreement with TD Bank Group (TD) for an additional five years of sponsorship. TD is the Official Bank of OverActive and OverActive's two Canadian professional esports teams - Toronto Ultra and Toronto Defiant - and has been collaborating with the Company in the gaming space for over two years. The sponsorship extension helps to unlock meaningful ways to engage and connect with customers and esports fans. The expanded sponsorship agreement between OverActive and TD addresses the following elements for 2022: Activation at both the Toronto Ultra Major III Tournament which took place from June 2 to 5, 2022 and the Toronto Defiant Summer Showdown scheduled for September 8 to 11, 2022. A remodel of the TD Player Lounge at OverActive's headquarters to provide an elevated experience for the Toronto Ultra and Toronto Defiant - in addition to the esports community at fan-facing events hosted at OverActive's facility. The return of Toronto Defiant's Fan Appreciation Weekend in August, which provides an opportunity to thank the team's dedicated fanbase with a watch party hosted at the TD Player Lounge where Toronto Defiant will face off against the Vancouver Titans. The launch of Canadian Overwatch Fest in collaboration with Toronto Defiant, a fan-centric weekend that celebrates the importance and diversity of the Overwatch community in Canada. Integration into Toronto Ultra and Toronto Defiant matches on the global Call of Duty and Overwatch League YouTube broadcasts, the creation of custom content and product placement opportunities.

07:37 EDT Applied Materials acquires Picosun Oy, terms not disclosed - Applied Materials, Inc. today announced it has acquired Picosun Oy, a privately held semiconductor equipment company based in Espoo, Finland. The company said, "Picosun is an innovator in atomic layer deposition technology, primarily for specialty semiconductors. As electronic products become smarter and more connected, they require greater numbers of specialty semiconductors built on non-leading-edge process nodes. Applied's ICAPS group provides materials engineering solutions to customers in these growing markets. The addition of Picosun's ALD technology broadens the Applied ICAPS product portfolio and customer engagements. Picosun also brings to Applied deep R&D capabilities, talented teams and strong relationships with leading research institutions and universities throughout the world." The Picosun team will continue to be based in Finland and will report into Applied's ICAPS group. The transaction has been approved by the Ministry of Economic Affairs and Employment of Finland; no other regulatory approvals were required. Financial terms of the transaction were not disclosed.

07:36 EDT Jushi Holdings issues statement on Commonwealth Court of Pennsylvania order - Jushi Holdings issued the following statement on the Commonwealth Court of Pennsylvania granting Medical Marijuana Access & Patient Safety's application to vacate the automatic stay of injunctive relief ordered on June 2, 2022, temporarily halting the Pennsylvania Department of Health's recall of certain vaporized medical marijuana products. The company said, "On behalf of Pennsylvania's medical marijuana patient community, we would like to extend our appreciation to the Commonwealth Court for its thoughtful assessment of the facts and circumstances upon which DOH's February recall of tested, approved medical marijuana vaporization products containing terpenes was based, and for the subsequent orders issued on June 2 and June 15 allowing responsible operators to again make these products accessible to patients. In light of the Court's Orders, impacted products will be back on the shelves of BEYOND/HELLO dispensaries today and the shelves of our partner dispensaries across the Commonwealth in the coming days. After receiving documents and testimony offered by MMAPS, the Court came to the unambiguous conclusion that DOH "failed to present any evidence" of potential harm to medical marijuana patients associated with the recalled products," noting that the Department did not call any witnesses or present any evidence of patient complaints or adverse events during the preliminary injunction hearing. Under Pennsylvania law, all medical marijuana products, including the recalled vaporization products, are subject to rigorous, redundant safety and quality testing and Department approval before they can be manufactured or dispensed. As to the recalled products specifically, DOH was neither able to cite a safety or quality testing deficiency nor a single adverse event relating to any recalled products. Nothing is more important to Jushi than the health and wellbeing of our customers, especially medical cannabis patients. We will continue to make best in class products available to Pennsylvanians suffering from serious medical conditions and support MMAPS' effort to ensure patients have access to tested, regulated products best suited to relieve their symptoms."

07:34 EDT Checkpoint Therapeutics announces interim results from trial on cosibelimab - Checkpoint Therapeutics announced positive interim efficacy results from its registration-enabling clinical trial evaluating its anti-PD-L1 antibody, cosibelimab, in patients with locally advanced cutaneous squamous cell carcinoma, cSCC, who are not candidates for curative surgery or radiation. The design of the interim analysis incorporated recent feedback from the U.S. Food and Drug Administration, FDA, and is intended to potentially support the approval of cosibelimab in this indication. As of the March 2022 data cutoff, the objective response rate determined by independent central review in 31 patients was 54.8%, substantially exceeding a clinically meaningful lower bound of the 95% two-sided confidence interval of 25%. Based on these positive results, Checkpoint intends to continue discussions with the FDA on the potential addition of locally advanced cSCC as a second indication in the planned Biologics License Application targeted for submission later this year. Checkpoint previously reported positive top-line data from a cohort of 78 patients with metastatic cSCC in its pivotal trial of cosibelimab. "These exciting positive interim results in this cohort of patients suggest a potential second indication for cosibelimab in locally advanced cSCC, which, when added to the potential labeling in the metastatic cSCC setting, could double the market opportunity at launch for cosibelimab globally," said James Oliviero, President and Chief Executive Officer of Checkpoint."Based on this compelling clinical profile, our planned market-disruptive pricing, and our patent protection through at least 2038, we believe cosibelimab has the opportunity to gain meaningful market share in the $32 billion and growing anti-PD-(L)1 class, while significantly lowering the barrier of high out-of-pocket costs patients endure worldwide to access existing premium-priced cancer therapies."

07:32 EDT Inozyme announces partnership with RCIGM to advance newborn screening - Inozyme Pharma announced a partnership with Rady Children's Institute for Genomic Medicine, RCIGM, to advance and evaluate a novel newborn screening technology to facilitate diagnosis of genetic diseases. The partnership includes several leading genomics, biotechnology companies and patient advocacy groups and focuses specifically on a diagnostic and precision medicine guidance tool called BeginNGS, which incorporates rapid Whole Genome Sequencing to currently screen newborns for approximately 400 genetic diseases. RCIGM is in a pilot evaluation that aims to supplement existing newborn screening protocols at birthing hospitals throughout the United States. The pilot program's goal is for BeginNGS to become the genetic disease screening standard, with testing expanding to approximately 1,000 and sequencing of 3.7 million newborns annually.

07:26 EDT Parsons selected by DHA on $10B Omnibus IV contract - Parsons Corporation was selected by the U.S. Defense Health Agency to provide health-related research and development and additional activities of interest for the Department of Defense and the Military Healthcare System. The $10B ceiling value Omnibus IV is a five-year multiple-award indefinite delivery/indefinite quantity contract with one five-year option period.

07:19 EDT Tronox sets 2025 adjusted EBITDA target of $1.3B-$1.5B - 2025 adjusted EBITDA target includes margins of 30% or greater. Sets 2025 free cash flow target of $750M-$850M or more and gross debt of less than $2B by year end 2025 and a net leverage ratio of 1.0x to 1.5x.

07:10 EDT Origin Materials, Kuraray announce carbon negative materials partnership - Origin Materials and Kuraray announced a strategic partnership to commercialize advanced carbon negative materials for diverse polymer applications. As part of the strategic partnership, Kuraray signed a capacity reservation agreement with Origin Materials to purchase sustainable, carbon negative intermediate chemicals used in the large-scale synthesis of many polymers, including PTA, PET, and polyamide. Origin's patented technology platform, which turns the carbon found in sustainable wood residues into useful materials, can help revolutionize the production of a wide range of end products and supports industry's transition to sustainable materials and lower GHG emissions.

07:09 EDT Petco launches new pet care retail centers for small-town and rural markets - Petco launched a new community-driven test concept designed to serve the health and wellness needs of pets and farm animals in small towns and rural communities. The opening of the first location will be in Floresville, Texas, June 17. Petco's new Neighborhood Farm & Pet Supply pet care centers feature brand-new, stand-alone retail locations situated at the heart of small-town and rural communities. The Neighborhood Farm & Pet Supply pet care centers will serve as one-stop shops for health and wellness solutions for pets and farm animals such as horses, cows, pigs, sheep, goats and more. With 14% of the U.S. population living in rural areas and that number rapidly growing, there is an estimated $7B total addressable market in small-town and rural locations. The launch of the test concept is expected to inaugurate a handful of Neighborhood Farm & Pet Supply pet care centers in 2022. Tailored to pets and farm animals of all shapes and sizes, the pet care centers will offer local events and an in-store community board to support interaction amongst neighbors.

07:09 EDT Enviva announces first shipment of sustainably sourced biomass from Mississippi - Enviva held a gathering at its newly opened terminal at the Port of Pascagoula, Mississippi on Wednesday, June 15, to commemorate the first shipment of sustainably sourced biomass to international power and heat producers, with a majority of the port's future shipments slated for Japan. Approximately 18,000 metric tons of sustainably sourced wood pellets produced at Enviva's newest plant in Lucedale, Mississippi were loaded onto the UBC Sacramento at the Port of Pascagoula destined for the ports of Pointe-a-Pitre, Guadeloupe and Fort-de-France, Martinique.

07:07 EDT GCM Mining reports Segovia May gold production 18,507 ounces - GCM Mining announced that its Segovia Operations produced 18,507 ounces of gold in May 2022, up from 17,936 ounces of gold in May last year. This brings the total gold production for the first five months of 2022 to 86,779 ounces, up from 84,467 ounces in the first five months last year. Segovia's trailing 12-months' total gold production at the end of May 2022 was 208,701 ounces, up about 1% over 2021. Expansion of the Company's processing plant at Segovia to 2,000 tonnes per day is nearing completion and is expected to be finished in July. The Company is on track to meet its annual production guidance for 2022 of between 210,000 and 225,000 ounces of gold. GCM Mining processed a total of 52,731 tonnes in May 2022 at its Maria Dama plant at Segovia, representing a daily processing rate of 1,701 tpd, compared with 49,089 tonnes and 1,584 tpd in May 2021. Segovia's head grades averaged 12.1 g/t in May 2022 compared with 12.6 g/t in May last year. For the first five months of 2022, a total of 246,352 tonnes were processed at Segovia at an average head grade of 12.2 g/t compared with a total of 229,747 tonnes at an average head grade of 12.7 g/t in the first five months last year. The Company also processed an average of 93 tpd of tailings in May 2022 at its polymetallic plant at Segovia resulting in the production of approximately 130 tonnes of zinc concentrate and approximately 94 tonnes of lead concentrate which have been stockpiled. The Company finalized the offtake contract for the concentrates earlier this month and is making preparation for the initial shipments which are expected to occur by the end of this month. Payable production from the concentrates in May 2022 is estimated to total approximately 114,000 pounds of zinc, 124,000 pounds of lead, 9,500 ounces of silver and less than 50 ounces of gold. Actual payable quantities are subject to change and will be finalized once the concentrates are shipped.

07:06 EDT Alto Ingredients receives $22.7M grant from USDA Program - Alto Ingredients, announced today that it has received a $22.7M cash grant from the USDA's Biofuel Producer Program. The Program was created as part of the CARES Act, which provided $700M to support biofuel producers who experienced market losses due to the COVID-19 pandemic.

07:05 EDT Canadian Solar acquires 400 MWh of storage projects under development - Canadian Solar's wholly owned subsidiary Recurrent Energy acquired two standalone energy storage projects from Black Mountain Energy Storage. The projects, which are in the South Load Zone of the Texas ERCOT market, are each anticipated to store up to 200 MWh of energy. Both projects are currently in development and are anticipated to reach notice to proceed in 2023 and begin operation in 2Q24. Recurrent has developed 2.9 GWh of energy storage projects that are in construction or operation and has an additional pipeline of 15.5 GWh of projects under early to mid-stage development. The transactions were executed through the LevelTen Asset Marketplace, a platform that connects clean energy project developers and financiers, and provides the software, analytics and M&A transaction expertise they need to execute transactions quickly.

07:05 EDT BioLineRx names Holly May as Chief Commercial Officer - BioLineRx announced that the company has appointed biopharmaceutical veteran executive Holly May as its Chief Commercial Officer. In this newly created role, based in the U.S., May will be responsible for the commercial planning, positioning and launch oversight for Motixafortide in the stem cell mobilization indication across the U.S. market, assuming FDA approval. BioLineRx remains on track to submit its New Drug Application to the FDA in mid-2022, consistent with prior guidance. Prior to joining BioLineRx, May served as Chief Commercial Officer at AVROBIO since September 2019.

07:03 EDT SSR Mining announces Normal Course Issuer Bid - SSR Mining is pleased to announce that it has filed with and received acceptance from the Toronto Stock Exchange for a Notice of Intention to make a Normal Course Issuer Bid under the requirements of the TSX permitting SSR Mining to purchase for cancellation up to 10,600,000 common shares of the company, representing approximately 5.0% of SSR Mining's total issued and outstanding Common Shares. As of June 6, SSR Mining had 212,638,432 issued and outstanding Common Shares.

07:02 EDT Tonix announces ribbon cutting ceremony for facility in Massachusetts - Tonix Pharmaceuticals announced it will hold a ribbon-cutting ceremony at the Company's 45,000 square foot clinical-scale manufacturing facility in the New Bedford Business Park in North Dartmouth, Massachusetts. The new facility houses Tonix's Advanced Development Center, ADC, for accelerated research, development and analytical capabilities, as well as the production of clinical trial quality vaccines for infectious diseases, including monkeypox, smallpox and COVID-19 as well as other infectious diseases for pandemic preparedness. "The opening of our new manufacturing facility in the New Bedford Business Park is a significant milestone for Tonix and we are excited to be part of the growing biotech industry in the South Coast region of Massachusetts," stated Seth Lederman, M.D., President and Chief Executive Officer of Tonix Pharmaceuticals. "The ADC greatly enhances our ability to progress our pipeline of vaccines for infectious diseases, including monkeypox, smallpox and COVID-19. We believe that the recombinant pox virus platform technology underlying our key vaccines in development, TNX-801, TNX-1840 and TNX-1850, coupled with our capabilities at the Tonix R&D Center for research and development, will be rapidly deployable for addressing potential novel or emerging pathogens, with simplified distribution and administration, relative to modified mRNA-based vaccines."

07:01 EDT Cigna announces $3.5B accelerated stock repurchase agreements - Cigna will repurchase $3.5B of common stock through accelerated stock repurchase agreements with Mizuho Markets Americas and Morgan Stanley & Co. The ASRs are part of Cigna's existing share repurchase program, which had remaining authority of approximately $8.8B as of June 14.

06:57 EDT M&T Bank COO Richard Gold to retire - Richard Gold, president and chief operating officer for M&T Bank has announced his intention to retire, effective after the first quarter of 2023. Gold plans to remain on the board of directors of M&T Bank.

06:55 EDT Activision Blizzard directors find no evidence executives ignored harassment - The independent directors of the Activision Blizzard board of directors issued an update on the work that the board and its Workplace Responsibility Committee of independent directors have been doing related to the company's workplace, which states in part: "The allegations in media and legal filings about our company were as distressing to us as they were to all of you. The Board resolved that we would dig into these issues directly, go where the facts took us, and that our work would be supplemented and informed by independent investigation and analysis conducted with the assistance of well respected, experienced outside experts with deep subject matter expertise. We committed to share our findings with you as well as updates on our progress toward becoming the model workplace we all aspire to be. Building and fostering an inclusive and welcoming workplace is an ongoing journey that must be top of mind for each of us every day... What we have come to realize over the past several months is that there are many truths about our company - individual and collective, experiential and data-driven - and sometimes they can be difficult to reconcile... Contrary to many of the allegations, the Board and its external advisors have determined that there is no evidence to suggest that Activision Blizzard senior executives ever intentionally ignored or attempted to downplay the instances of gender harassment that occurred and were reported. That work also has not unearthed any evidence, directly or indirectly, suggesting any attempt by any senior executive or employee to conceal information from the Board. Outside advisors, after exhaustive review, also determined the Board never intentionally ignored or attempted to downplay the instances of gender harassment that occurred and were reported. The review of contemporaneous documentation and statements by relevant individuals shows that media criticism of the Board and Activision Blizzard senior executives as insensitive to workplace matters is without merit. Activision Blizzard senior executives responded in a timely manner and with integrity and resolve to improve the workplace. While there are some substantiated instances of gender harassment, those unfortunate circumstances do not support the conclusion that Activision senior leadership or the Board were aware of and tolerated gender harassment or that there was ever a systemic issue with harassment, discrimination or retaliation... We recognize none of these improvements can change the past for those who experienced inappropriate workplace conduct. Over the years the Company has appropriately disciplined and exited employees to ensure that our practices match our policies. There simply is no room at Activision Blizzard for anyone who does not practice our corporate value of providing a safe, inclusive and welcoming workplace that serves as a model for our industry... Our recent settlement with the EEOC is already available for eligible employees to submit claims. The Company is not involved in the claims review process and all decisions are made by the EEOC. We understand that moving forward includes addressing the issues of the past. The EEOC consent decree, with the transparency, enhanced mental health benefits for any victims of harassment (regardless of where they were employed when those events occurred), as well as the compensation it provides, is just part of that effort. Another is the $250 million dollar investment we are making in the people who create our world-class entertainment and whose shared purpose improves our culture. The inaugural class of Level Up U focused on training applicants for engineering positions is about to begin: as of June 15, 2022, 103 offers were accepted with a 73% rate of overall diversity, including 45% women and non-binary individuals and 40% from underrepresented ethnic groups. Across the Company overall we are working to improve representation in every business unit. This is of foundational importance as we look ahead. While the Board and management have implemented the above steps to continue to improve the workplace, it must be said that the Company has been subject to an unrelenting barrage of media criticism that attempts to paint the entire Company (and many innocent employees) with the stain of a very small portion of our employee population who engaged in bad behavior and were disciplined for it. Much of this originated with the highly inflammatory, made-for-press allegations of the DFEH. As our outside advisors made clear, the DFEH was not assigned to investigate harassment in its agreement with the EEOC, nor did it in fact complete an investigation into issues of harassment at Activision Blizzard. There has also been no court finding, verdict, or ruling concluding the DFEH allegations to be true. In fact, the DFEH's efforts to interfere with the EEOC settlement, which was determined to be fair and reasonable by a federal court, have been denied six times. That said, rather than dismiss these criticisms, the Board and management have taken these allegations seriously and according to outside advisors, have investigated these appropriately." Reference Link

06:49 EDT SQZ Biotechnologies' Cell Squeeze technology generates dopaminergic neurons - SQZ Biotechnologies presented preclinical regenerative medicine data showing that the company's proprietary Cell Squeeze technology can effectively generate dopaminergic neurons from human-induced pluripotent stem cells through the single-step delivery of six RNA that encode for specific fate-determining transcription factors. The new findings build upon the company's recent regenerative medicine research presentations and are aligned with the company's NIH-funded effort to generate cell replacement therapies for neurodegenerative conditions like Parkinson's disease. By combining and delivering Ascl1 saRNA, a key neuronal transcription factor, with five mRNA transcription factors, SQZ scientists were able to differentiate iPSCs into dopaminergic neurons. A single Cell Squeeze delivery of saRNA and mRNA transcription factors into human iPSCs induced a 25,000-fold increase in the expression of the FOXA2 gene, a key marker for dopaminergic neurons, in four days. Together, these data show the potential of the Cell Squeeze(R) technology to reprogram cells for regenerative medicine applications, including Parkinson's disease.

06:46 EDT Ring Energy set to join Russell 3000 index - Ring Energy announced it is set to join the broad-market Russell 3000 Index at the conclusion of the 2022 Russell Indexes Annual Reconstitution, according to a preliminary list of additions posted by FTSE Russell on June 3. Inclusion in the index will take effect after the U.S. market opens on June 27.

06:38 EDT Roche launches human papillomavirus self-sampling solution - Roche announced the launch of a human papillomavirus, or HPV, self sampling solution in countries accepting the CE mark. This new solution enables a patient to privately collect her sample for HPV screening while at a healthcare facility, following instructions provided by a healthcare worker. The clinically-validated vaginal sample is analyzed with the Roche cobas HPV test on a Roche molecular instrument.

06:33 EDT Senseonics announces CE Mark approval of Eversense E3 CGM System - Senseonics announced that it has received CE Mark approval for the next-generation Eversense E3 CGM System, the longest-lasting system available, with exceptional accuracy. The CE Mark approval confirms that the Eversense E3 meets the requirements of the European Medical Device Regulation, and enables the commercialization of Eversense E3 in European Union member countries. Senseonics' commercial partner, Ascensia Diabetes Care, will make the improved system, which can be used for up to 6 months, available from the third quarter of 2022. Following the CE Mark approval in Europe, the E3 System will be distributed in Germany, Italy, Spain (including Andorra), the Netherlands, Poland, Switzerland, Norway and Sweden.

06:10 EDT BHP to retain NSWEC, wind down thermal coal mine after failing to find buyer - BHP announced that it will retain New South Wales Energy Coal in its portfolio, seek the relevant approvals to continue mining beyond its current mining consent that expires in 2026 and proceed with a managed process to cease mining at the asset by the end of the 2030 financial year. The decision follows BHP's review of its lower grade metallurgical and energy coal assets that was announced in August 2020 and has also resulted in the divestment of our interests in Cerrejon and BHP Mitsui Coal in January and May 2022 respectively. A trade sale process for NSWEC was conducted however the process did not result in a viable offer, the company said in a statement. Assessment of the resource economics, geotechnical profile and future investment requirements determined that continued mining in the near term and moving to a closure in 2030 provides the optimal financial outcome when compared to alternate options, it added.

06:01 EDT Jiayin Group authorizes $10M share repurchase plan - Jiayin Group has authorized a share repurchase plan under which the company may repurchase its ordinary shares with an aggregate value of $10M during the 12-month period beginning on June 13. The company plans to fund repurchases from its existing cash balance.

05:26 EDT Exelixis, BioInvent enter license agreement for antibodies in IO therapeutics - Exelixis and BioInvent announced that the companies have entered into an option and license agreement focused on the identification and development of novel antibodies for use in IO therapeutics. The collaboration is intended to expand Exelixis' portfolio of antibody-based therapies and will combine BioInvent's cancer immunology and antibody biology expertise with Exelixis' expertise and resources in antibody engineering and antibody-drug conjugate, or ADC, technologies, and proven history of developing and commercializing oncology therapeutics. Target and antibody discovery will be performed using BioInvent's proprietary n-CoDeR antibody library and patient-centric F.I.R.S.T screening platform, which together allow for parallel target and antibody discovery. Under the terms of the agreement, Exelixis will pay BioInvent an upfront fee of $25M in exchange for rights to select three targets identified using BioInvent's proprietary F.I.R.S.T platform and n-CoDeR library. BioInvent will be responsible for initial target and antibody discovery activities, and characterization of antibody mechanism of action. Exelixis will have the right to exercise an option to in-license any of the target programs upon identification of a development candidate directed to that target. Upon option exercise, Exelixis will pay BioInvent an option exercise fee and will assume responsibility for all future development and commercialization activities for the development candidate, including potential ADC and bispecific antibody engineering activities. In addition, BioInvent will be eligible for success-based development and commercialization milestones, as well as tiered royalties on the annual net sales of any products that are successfully commercialized under the collaboration.

05:20 EDT Amazon announces Prime Day to be held on July 12 - Amazon's annual Prime Day event is back. The 48-hour event kicks off July 12 at 3 a.m. EDT and runs through July 13 for Prime members in Austria, Australia, Belgium, Brazil, Canada, China, France, Germany, Italy, Japan, Luxembourg, Mexico, the Netherlands, Portugal, Singapore, Spain, the U.K., the U.S., and for the first time ever in Poland and Sweden. Later this summer, Prime Day deals events will be held in India, Saudi Arabia, and the United Arab Emirates, as well as in Egypt for the first time.

05:12 EDT Wejo develops autonomous vehicle platform AV-OS - Wejo announced its smart platform, Wejo Autonomous Vehicle Operating System, or AV-OS. AV-OS is set to rapidly accelerate the development and adoption of AVs for automakers and fleet developers by opening up and democratizing access to connected vehicle data, or CVD. Announced at MOVE 2022, held at London's Excel 15-16 June, The AV-OS platform will leverage billions of daily data points from millions of connected vehicles, including AV data, to generate AV outcomes. Interpreted and analyzed by Wejo's Smart Mobility intelligence offerings, the platform will unlock insights for any AV developers supporting the acceleration of AV testing, carried out in a virtual simulation environment. Democratizing access to data, the AV-OS platform will remove the silos of traditional development processes that AV OEMs must go through, enabling rapid innovation. Turning the raw connected vehicle data into insights, Wejo helps developers better understand vehicles, journeys, roads, and locations to create driving experiences.

04:40 EDT Kazia Therapeutics granted orphan status for paxalisib - The FDA granted Kazia Therapeutics orphan status for paxalisib, its treatment of atypical teratoid/rhabdoid tumors. Reference Link